Treating autoimmune diseases with humanized anti-CD40L antibody
The present invention is directed to humanized antibodies which bind human gp39 and their use as therapeutic agents. These humanized antibodies are especially useful for treatment of autoimmune diseases; and an immunosuppressant during transplantation of heterologous cells, tissues or organs, cell t...
Saved in:
Main Authors | , , , |
---|---|
Format | Patent |
Language | English |
Published |
17.10.2006
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | The present invention is directed to humanized antibodies which bind human gp39 and their use as therapeutic agents. These humanized antibodies are especially useful for treatment of autoimmune diseases; and an immunosuppressant during transplantation of heterologous cells, tissues or organs, cell therapy, and gene therapy. |
---|---|
Bibliography: | Application Number: US20020171681 |